Related Experiment Video

Updated: Aug 15, 2026

Imaging CD4 T Cell Interstitial Migration in the Inflamed Dermis
11:28

Imaging CD4 T Cell Interstitial Migration in the Inflamed Dermis

Published on: March 25, 2016

Outcome in juvenile dermatomyositis

Vaidehi Chowdhary1, Anupam Wakhlu, Amita Agarwal

  • 1Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Barielly Road, Lucknow. rnmisra@sgpgi.ac.in

Indian Pediatrics
|November 13, 2002
PubMed

Insights

Early recognition and aggressive treatment of juvenile dermatomyositis (JDM) are crucial for improving patient outcomes. This study highlights key clinical features, treatment responses, and complications in pediatric JDM cases.

Area of Science:

  • Pediatric Rheumatology
  • Immunology

Background:

  • Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children.
  • Understanding its clinical spectrum, treatment, and complications is vital for effective management.

Purpose of the Study:

  • To analyze the clinical features, outcomes, and complications of juvenile dermatomyositis.
  • To evaluate treatment responses and identify factors influencing prognosis in JDM patients.

Main Methods:

  • Retrospective analysis of case records from a tertiary care hospital.
  • Inclusion of 19 patients diagnosed with juvenile dermatomyositis over an 11-year period.
  • Review of clinical manifestations, diagnostic delays, treatment regimens, and patient outcomes.

Main Results:

  • Proximal muscle weakness, heliotrope rash, and Gottron's rash were common presenting features.
  • Complications included calcinosis, contractures, tuberculosis, and pyogenic infections.
  • Significant rates of complete and partial remission were observed with prednisolone and methotrexate treatment.

Conclusions:

  • Juvenile dermatomyositis requires prompt diagnosis and aggressive therapeutic strategies.
  • Early intervention can lead to improved remission rates and reduced long-term complications.
  • Multidisciplinary care is essential for managing the diverse clinical manifestations of JDM.

More Related Videos

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

Related Concept Videos

Papillary Dermis01:11

Papillary Dermis

Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Reticular Dermis01:15

Reticular Dermis

The papillary and reticular dermis are the two layers of the dermis. They are made of connective tissue with fibers of collagen extending from one to the other, making the border between the two somewhat indistinct. The dermal papillae extending into the epidermis belong to the papillary layer, whereas the dense collagen fiber bundles below belong to the reticular layer.
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...